IBB, GULF, GDP, DBOEY, Added To Naked Short Lists Today
M2 - Mon Oct 13, 10:51AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Ishares Nasdaq Biotechnology (NASDAQ:IBB), WisdomTree Middle East Dividend Fund (NASDAQ:GULF), Goodrich Petroleum Corp (NYSE:GDP), Deutsche Boerse AG (OTC
GDP: 11.03 (+1.55), GULF: 22.47 (+0.47), IBB: 260.98 (+4.51)
iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.09%
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 260.98 (+4.51)
After Yesterday's Decline of 2.09%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 260.98 (+4.51)
'Fast Money' Recap: Relief About the Stock Market Rally
at The Street - Thu Oct 09, 4:00AM CDT
The trading panel discussed where they are putting their money after the change in market direction.
F: 13.98 (+0.36), LMT: 174.72 (-0.47), ARWR: 7.02 (+0.55), XOP: 59.33 (+2.68), XBI: 156.59 (+4.37), C: 49.75 (+0.07), M: 56.57 (+0.57), IBB: 260.98 (+4.51), SHLD: 30.00 (+0.44), AA: 14.60 (+0.10), TJX: 59.62 (-0.48), RIG: 30.15 (+0.71), GILD: 96.88 (+0.72), GLD: 119.22 (+0.23), TGT: 59.44 (-0.54), JCP: 7.30 (+0.21), GM: 29.94 (+0.25), GOOGL: 536.92 (-3.81), GPS: 36.49 (+0.55), TWTR: 48.23 (-1.76), XLE: 82.00 (+1.44)
'Fast Money' Recap: What Should You Buy in a Declining Market?
at The Street - Wed Oct 08, 4:00AM CDT
The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.
PEI: 19.46 (+0.31), CLR: 55.92 (+2.07), GMCR: 137.98 (-1.63), TKMR: 22.81 (-1.09), IBB: 260.98 (+4.51), M: 56.57 (+0.57), JBLU: 11.22 (+0.92), UPS: 95.63 (-0.82), PEP: 90.79 (-0.98), SBUX: 72.64 (+0.26), AGN: 178.00 (+0.41), SAVE: 55.66 (+1.69), CMRX: 35.40 (+3.22), EOG: 91.27 (+3.10), DPZ: 83.93 (+0.28), COST: 122.95 (-1.35), GOOGL: 536.92 (-3.81), CMLS: 3.57 (+0.28), AAPL: 96.26 (-1.28), MBLY: 46.46 (+1.11), YUM: 67.62 (+0.39), APC: 89.57 (+4.11), AMBA: 38.76 (+0.16), AEC: 18.52 (-0.09), GPRO: 72.69 (-0.18), ETN: 59.92 (+0.95), IR: 54.91 (+0.97), GSK: 42.88 (-0.25), PXD: 177.92 (+6.34), MCD: 89.91 (-0.53), GM: 29.94 (+0.25), IWM: 107.80 (+1.20), SODA: 21.09 (-0.12)
Why Is George Soros Buying Celgene Corporation?
George Budwell, The Motley Fool - Motley Fool - Mon Oct 06, 9:01AM CDT
Superinvestors have transcended the investing landscape for one simple reason: they are awfully good at making money. Many smaller investors therefore like to track the movements of these "elephants" to see what they are buying and selling in hopes...
IBB: 260.98 (+4.51), CELG: 86.38 (-0.17)
The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 45.11 (+0.88), FBT: 88.68 (+1.34), XBI: 156.59 (+4.37), BBH: 99.59 (+1.45), IBB: 260.98 (+4.51)
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.50% Loss
Comtex SmarTrend(R) - Wed Oct 01, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $267.58 to a high of $273.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $272.22 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 260.98 (+4.51)
'Fast Money' Recap: How to Trade After the Market's Drop
at The Street - Fri Sep 26, 4:00AM CDT
The trading panel likes the idea of buying Microsoft, Intel and other tech stocks if the market opens lower Friday
BIIB: 302.74 (-2.95), NKE: 87.04 (+1.86), XBI: 156.59 (+4.37), BBRY: 9.30 (+0.19), IBB: 260.98 (+4.51), INTC: 30.85 (-0.42), YHOO: 38.12 (+0.30), DD: 66.23 (-0.20), GOOGL: 536.92 (-3.81), MSFT: 42.74 (-0.48), AAPL: 96.26 (-1.28), REGN: 340.71 (+5.96), AMZN: 302.86 (-3.11), MU: 28.30 (+0.76), VRTX: 101.26 (+0.16), EMN: 74.34 (+0.87), FB: 72.63 (-0.58), BRCM: 35.31 (-0.15), PFE: 27.70 (-0.49), AMGN: 130.45 (-0.45), TIF: 90.72 (+2.95), HPQ: 34.00 (+1.20), PCLN: 1,073.19 (+14.44), LULU: 40.00 (+0.40), MHR: 4.99 (+0.45), GILD: 96.88 (+0.72), FNV: 54.69 (-0.75), RGLD: 68.87 (+1.00), IWM: 107.80 (+1.20), DOW: 44.76 (+0.67), BABA: 88.85 (+3.25), AN: 48.22 (+0.22)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.80% Gain
Comtex SmarTrend(R) - Wed Sep 24, 3:51PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $272.71 to a high of $279.55. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $277.23 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 260.98 (+4.51)
BioShares Plans Two Innovative Biotech ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Sep 24, 7:00AM CDT
BioShares is looking to launch some very unique biotechnology ETFs soon.
FBT: 88.68 (+1.34), XBI: 156.59 (+4.37), IBB: 260.98 (+4.51)
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
TSLA: 226.35 (-3.35), XBI: 156.59 (+4.37), IBB: 260.98 (+4.51), JBLU: 11.22 (+0.92), DEO: 110.14 (+0.37), NOK: 7.80 (+0.03), YHOO: 38.12 (+0.30), EBAY: 47.88 (-2.36), PLCE: 48.23 (+0.20), TWTR: 48.23 (-1.76), MSFT: 42.74 (-0.48), AAPL: 96.26 (-1.28), REGN: 340.71 (+5.96), AMZN: 302.86 (-3.11), ABX: 13.78 (+0.23), NADL: 5.60 (+0.06), DRI: 48.36 (+0.12), CELG: 86.38 (-0.17), AA: 14.60 (+0.10), BIDU: 211.22 (+5.49), TSO: 59.81 (+1.17), GILD: 96.88 (+0.72), ACHN: 10.89 (+0.76), IWM: 107.80 (+1.20), BF.B: 83.84 (+0.23), CRM: 53.87 (+0.78)
iShares Nasdaq Biotechnology Index Falls 1.26% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Sep 15, 3:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $263.64 to a high of $268.99. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $268.24 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 260.98 (+4.51)
3 Reasons Actavis plc Stock Could Fall
George Budwell, The Motley Fool - Motley Fool - Mon Sep 15, 10:50AM CDT
Healthcare and biotechnology stocks have put on another amazing show this year, with the closely watched iShares Nasdaq Biotechnology Index pushing higher by nearly 19% so far. And certain subsectors, including generic and specialty...
ACT: 222.07 (+4.83), IBB: 260.98 (+4.51), TEVA: 51.56 (+1.47)
WIT, IBB, EROC, MPX, SEP, TUZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Sep 15, 4:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Wipro Ltd (NYSE:WIT), Ishares Nasdaq Biotechnology (NASDAQ:IBB), EAGLE ROCK ENERGY PARTNERS (NASDAQ:EROC), Marine Products Corp (NYSE:MPX), Spectra Energy Partners LP (NYSE:SEP), PimCo 1 3 Year Us Treasury Index Fund (NYSE:TUZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
MPX: 8.21 (+0.32), WIT: 12.06 (-0.16), TUZ: 51.14 (-0.03), SEP: 50.76 (+1.11), IBB: 260.98 (+4.51), EROC: 3.16 (+0.39)